JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders
Open Access
- 21 February 2008
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 22 (7) , 1454-1455
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Analysis of the exon 12 and 14 mutations of the JAK2 gene in Philadelphia chromosome-positive leukemiaLeukemia, 2007
- Reply to ‘Myeloproliferative disorders with coexisting BCR-ABL translocation and JAK2V617F mutation’ by Dr Ronald S GoLeukemia, 2007
- Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosisLeukemia, 2007
- Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutationBlood, 2007
- In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 alleleExperimental Hematology, 2007
- Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemiaLeukemia, 2007
- Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosisLeukemia, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR‐ABL transcriptBritish Journal of Haematology, 1996
- Transformation of polycythemia vera to ph‐positive chronic myelogenous leukemiaAmerican Journal of Hematology, 1990